social_molmed

molmed molmed tk molmed ngr-htnf ngr-htnf molmed ngr htnf tk conditional marketing authorisation molmed european cancer congress molmed asco molmed claudio bordignon molmed ngr-htnf asco molmed ngrhtnf asco molmed ngrhtnf claudio bordignon molmed sarcoma molmed consiglio amministrazione molmed cell gene therapy molmed tk bmt molmed board of molmed ngr-htnf mesothelioma molmed ngr-htnf mesotelioma molmed tk leucemia molmed tk asco malignant pleural mesothelioma mesotelioma pleurico maligno molmed interim financial report 2013 molmed trimestrale 2013 phase iii tk united states molmed leukaemia united states molmed phase iii tk fase iii tk stati uniti molmed leucemie stati uniti molmed fase iii tk molmed soft tissues sarcomas molmed sarcomi tessuti molli molmed board molmed shareholder meeting molmed consiglio amministrazione molmed assemblea azionisti molmed consiglio amministrazione molmed assemblea azionisti molmed consiglio amministrazione molmed assemblea azionisti molmed assemblea azionisti ngr-htnf patent office ngr-htnf brevetto europeo molmed board directors consiglio amministrazione molmed molmed acute leukaemias molmed leucemie acute mesothelioma molmed faseiii ngr-htnf mesotelioma molmed mesotelioma recidivante farmaco antitumorale sperimentale molmed tk ash molmed benefici tk esmo congress 2012 congresso esmo 2012